As part of the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) program, the efficacy of once-weekly subcutaneous semaglutide was evaluated in over 7,000 patients in six global phase IIIa trials (SUSTAIN 16) across the wide spectrum of the T2D disease course ( Table 1 )
Changes in Appetite and Caloric Intake Affecting Energy Levels One of semaglutides main effects is reducing appetite
(1) (2) (3) (4) (5) (6) Eric Verdin, Euan Ashley, Joseph C
If your GLP-1 side effects are hitting hard, the session adapts
This ongoing support helps prevent weight regain and keeps you feeling your best
You may be studying or working too hard, caring for a sick relative, or experiencing other trials and tribulations for an extended period, resulting in increased stress and brain fog